Weekly Digest – November 2024 Weekly Digest – November 2024 14 Nov 2024: Mabwell’s Novel Nectin-4 Targeting ADC 9MW2821 Approved for 2 Clinical Trials by CDE of NMPA Mabwell’s novel Nectin-4 targeting ADC, 9MW2821, has received IND approval for two […]
Weekly Digest – November 2024 Weekly Digest – November 2024 12 Nov 2024: Datopotamab Deruxtecan New BLA Submitted for Accelerated Approval in the U.S. for Patients with Previously Treated Advanced EGFR-Mutated Non-Small Cell Lung Cancer Daiichi Sankyo and AstraZeneca have […]
Weekly Digest – November 2024 Weekly Digest – November 2024 12 Nov 2024: AstraZeneca, Daiichi withdraw lung cancer approval application for Enhertu follow-up and try again Daiichi Sankyo and AstraZeneca have withdrawn their FDA application for Dato-DXd in non-squamous non-small […]
